Get the Stockscreener App
3.01
1.01%
0.03
After Hours:
3.02
0.01
+0.33%
Orasure Technologies Inc stock is traded at $3.01, with a volume of 348.29K.
It is up +1.01% in the last 24 hours and up +3.79% over the past month.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
See More
Previous Close:
$2.98
Open:
$3.02
24h Volume:
348.29K
Relative Volume:
0.61
Market Cap:
$215.92M
Revenue:
$405.47M
Net Income/Loss:
$53.66M
P/E Ratio:
4.1806
EPS:
0.72
Net Cash Flow:
$131.28M
1W Performance:
+7.50%
1M Performance:
+3.79%
6M Performance:
-4.44%
1Y Performance:
-10.68%
1-Day Range:
$2.96
$3.08
1-Week Range:
$2.51
$3.2154
52-Week Range:
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.01 | 213.77M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Resumed | Evercore ISI | In-line |
| Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-21-20 | Initiated | Evercore ISI | Outperform |
| Aug-10-20 | Initiated | Citigroup | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
| Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-25-20 | Initiated | Lake Street | Buy |
| Apr-21-20 | Resumed | Stephens | Equal-Weight |
| Oct-23-18 | Resumed | Raymond James | Mkt Perform |
| Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-05-15 | Reiterated | Mizuho | Buy |
| May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-23-15 | Reiterated | Mizuho | Buy |
| Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
| Jun-11-14 | Reiterated | Mizuho | Buy |
| Dec-21-12 | Initiated | Mizuho | Buy |
| Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes - Stock Titan
OraSure Technologies, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OSUR) 2026-03-03 - Seeking Alpha
Healthy Trucking Association Launches Hepatitis C Initiative - Heavy Duty Trucking
OSUR Should I Buy - Intellectia AI
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OraSure Technologies (OSUR) Loss Worsens To US$0.27 EPS And Tests Margin Recovery Narrative - Sahm
OraSure Technologies Q4 Earnings Call Highlights - MarketBeat
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights - GuruFocus
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches - MSN
Earnings Call Summary | OraSure Technologies(OSUR.US) Q4 2025 Earnings Conference - 富途牛牛
OraSure: Fourth Quarter Financial Results Overview - Bitget
OraSure Technologies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Earnings call transcript: OraSure Technologies Q4 2025 earnings fall short of revenue expectations - Investing.com
OraSure: Q4 Earnings Snapshot - Barchart.com
OraSure Technologies (OSUR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
OraSure Highlights 2025 Results and 2026 Growth Outlook - TipRanks
OraSure Announces Fourth Quarter 2025 Financial Results - The Manila Times
Revenue drops as OraSure (NASDAQ: OSUR) posts deeper 2025 loss - Stock Titan
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies (OSUR) Expected to Announce Earnings on Wednesday - MarketBeat
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
How sensitive is OraSure Technologies Inc. to inflationJuly 2025 Setups & Verified Chart Pattern Signals - mfd.ru
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test approved for sale in Canada - CBC
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
Orasure to Launch Oraquick?? Hiv Self-Test in Canada - marketscreener.com
OraSure’s HIV self-test receives Health Canada license - Investing.com
OraSure to Launch OraQuick™ HIV Self-Test in Canada - ChartMill
At-home oral HIV self-test approved for sale in Canada - Toronto Sun
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Treasury Yields: How does OraSure Technologies Inc perform in inflationary periodsJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Aug Rallies: Should I set a stop loss on PATH2025 Risk Factors & Long Hold Capital Preservation Tips - baoquankhu1.vn
Does OraSure Technologies Inc. have a sustainable dividendEarnings Growth Summary & Long-Term Capital Growth Strategies - mfd.ru
Investment Review: Can OraSure Technologies Inc maintain sales growth2025 Support & Resistance & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Ideas: Is ATHM in a bullish channelEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn
OraSure files for FDA review of molecular self-test & Colli-Pee device - MSN
Risk Analysis: Does OraSure Technologies Inc. have a sustainable dividend2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
Is OraSure Technologies Inc. stock attractive for growth ETFsPortfolio Value Report & Verified Short-Term Plans - bollywoodhelpline.com
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):